Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Glycosciences and FDA to Study Proteomics of Toxicology

NEW YORK, Sept. 19-Oxford Glycosciences will work jointly with researchers at the U.S. Food and Drug Administration's drug evaluation center to identify serum protein biomarkers related to drug toxicity, the company said today.

 

The collaboration is a Cooperative Research and Development Agreement struck with the FDA Center for Drug Evaluation and Research.

 

FDA researchers will develop models of drug-induced toxic injury to heart, vascular and liver tissue and will generate biological samples from these experiments. OGS scientists will use the company's proteomics techniques to analyze these samples and identify serum markers specific to toxic response.

 

Under the terms of a CRADA, the FDA shares resources, personnel, expenses, and expertise with private industry partners, but does not provide direct funding.

 

For more information, see the press release.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.